Thomas E Polen Jr sold $768k of BDX
Chairman, CEO and President at BECTON DICKINSON & CO. 4,152 shares at an average of $185.00, traded Aug 13, 2026, filed Aug 14, 2026.
Score components
- +25RoleCEO
- +22Trade size$768k at market
- 0Share of holdings soldSold 3.6% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-26-057166, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | MOption exercise Common Stock10b5-1 | +43,278 | $167.25 | $7.2M | 153,441 | Aug 14, 2026 |
| Aug 13, 2026 | DDisposition to issuer Common Stock10b5-1 | -39,126 | $185.00 | $7.2M | 114,315 | Aug 14, 2026 |
| Aug 13, 2026 | SOpen-market sale Common Stock10b5-1 | -4,152 | $185.00 | $768k | 110,163 | Aug 14, 2026 |
| Aug 13, 2026 | MOption exercise Stock Appreciation Rightsderivative10b5-1 | -43,278 | $0.00 | $0 | 0 | Aug 14, 2026 |
Related signals
Other insiders at BECTON DICKINSON & CO and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | BECTON DICKINSON & CO | Michael Feld EVP, Chief Revenue Officer | $14k 76 shares | -0% | |
| 8Weak | BECTON DICKINSON & CO | Michael Feld EVP, Chief Revenue Officer | $31k 165 shares | -1% | |
| 45Moderate | BECTON DICKINSON & CO | Roland Goette EVP and President, EMEA | $441k 2,438 shares | -14% | |
| 0Weak | BECTON DICKINSON & CO | Michael Feld EVP, Chief Revenue Officer | $12k 75 shares | -0% | |
| 3Weak | BECTON DICKINSON & CO | Michael Feld EVP, Chief Revenue Officer | $11k 75 shares | -0% | |
| 14Weak | BECTON DICKINSON & CO | Michael David Garrison EVP & Pres Med.Essntl&BioPharm | $160k 1,100 shares | -8% | |
| 14Weak | BECTON DICKINSON & CO | Michael David Garrison EVP & Pres Med.Essntl&BioPharm | $167k 1,100 shares | -7% | |
| 21Weak | BECTON DICKINSON & CO | Thomas E Polen Jr Chairman, CEO and President | $405k 2,764 shares | -2% | |
| 3Weak | BECTON DICKINSON & CO | Michael Feld EVP, Chief Revenue Officer | $11k 75 shares | -0% | |
| 0Weak | BECTON DICKINSON & CO | Michael Feld EVP, Chief Revenue Officer | $11k 74 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.